BioPharma Credit PLC Result of General Meeting (0859Y)
28 Dezember 2023 - 12:04PM
UK Regulatory
TIDMBPCR
RNS Number : 0859Y
BioPharma Credit PLC
28 December 2023
BIOPHARMA CREDIT PLC
(THE "COMPANY")
RESULT OF GENERAL MEETING
The Company is pleased to announce that, at the General Meeting
held today, the resolution put to the meeting was passed by way of
a poll.
Votes % % Votes Withheld(1)
Resolution For Votes Against
To approve the
continuation of
the Company's
business as a
closed-ended investment
trust. 704,196,309 94.06 44,493,800 5.94 21,716
------------ ------ -------------- ----- ------------------
1. A 'vote withheld' is not a vote under English law and is not
counted in the calculation of votes 'for' or 'against' a
resolution.
A copy of the resolution has been submitted to the National
Storage Mechanism and will shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
28 December 2023
Enquiries
BioPharma Credit plc
via Link Company Matters Limited
Company Secretary
T. +44 (0) 333 300 1950
Buchanan
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
+44 (0) 20 7466 5000
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor
in debt from the life sciences industry and joined the LSE on 27
March 2017. The Company seeks to provide long-term shareholder
returns, principally in the form of sustainable income
distributions from exposure to the life sciences industry. The
Company seeks to achieve this objective primarily through
investments in debt assets secured by royalties or other cash flows
derived from the sales of approved life sciences products.
LEI: 213800AV55PYXAS7SY24
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ROMFVLFLXLLBFBX
(END) Dow Jones Newswires
December 28, 2023 06:04 ET (11:04 GMT)
Biopharma Credit (LSE:BPCP)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Biopharma Credit (LSE:BPCP)
Historical Stock Chart
Von Dez 2023 bis Dez 2024